Literature DB >> 832515

Blood and urinary concentrations of fosfomycin as a function of the renal function value.

M Neuman, G Fluteau.   

Abstract

The following parameters were considered in studying 43 subjects under treatment for urinary infections with different degrees of renal insufficiency: the maximum blood concentrations, the plasmatic half-life, and the urinary concentrations of fosfomycin as a function of the plasma creatinine of the subject treated. The curve of the average maximum blood concentrations show a parabola-like increase, the plasmatic half-life followed the same tendency, while the curve of the average urinary concentrations presented an exponential decrease. The urinary concentrations were, nevertheless, always higher than 100 mug/ml regardless of the degree of renal insufficiency and even in the subjects who had a very high plasma creatinine. Given its absence of renal and systemic toxicity, the daily dosage of fosfomycin could remain unchanged regardless of the degree of insufficiency.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 832515     DOI: 10.1159/000222047

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  3 in total

1.  Pharmacokinetics of phosphomycin during haemofiltration.

Authors:  C Fernandez Lastra; E L Mariño; A Dominguez-Gil; J M Tabernero; J Grande Villoria
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

Review 2.  Fosfomycin: Pharmacological, Clinical and Future Perspectives.

Authors:  Anneke Corinne Dijkmans; Natalia Veneranda Ortiz Zacarías; Jacobus Burggraaf; Johan Willem Mouton; Erik Bert Wilms; Cees van Nieuwkoop; Daniel Johannes Touw; Jasper Stevens; Ingrid Maria Catharina Kamerling
Journal:  Antibiotics (Basel)       Date:  2017-10-31

Review 3.  Urinary tract infections in patients with renal insufficiency and dialysis - epidemiology, pathogenesis, clinical symptoms, diagnosis and treatment.

Authors:  Jürgen E Scherberich; Reinhard Fünfstück; Kurt G Naber
Journal:  GMS Infect Dis       Date:  2021-12-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.